Autophagy Functions to Prevent Methylglyoxal-Induced Apoptosis in HK-2 Cells

Area of Science:

• Cell Biology
• Molecular Biology
• Nephrology

Background:

• Methylglyoxal (MGO) is a reactive carbonyl species linked to kidney damage, especially in diabetic nephropathy.
• MGO induces both apoptosis and autophagy, but their interplay in cellular response remains unclear.

Purpose of the Study:

• To investigate if autophagy acts as a protective mechanism against MGO-induced apoptosis in kidney cells.
• To elucidate the signaling pathways involved in MGO-induced autophagy.

Main Methods:

• HK-2 cells were treated with MGO to assess apoptosis and autophagy markers (p62, LC3-II).
• ATG5-knockdown cells were used to evaluate the role of autophagy in MGO-induced apoptosis.
• The AKT/mammalian target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) signaling pathways were analyzed.

Main Results:

• MGO induced concentration- and time-dependent apoptosis in HK-2 cells.
• MGO upregulated autophagy markers (p62, LC3-II), and inhibiting autophagy (ATG5 knockdown) exacerbated MGO-induced apoptosis.
• Autophagy activation reduced MGO-induced cell death, and MGO-induced autophagy involved AMPK-mediated transcription factors, not AKT/mTOR signaling.

Conclusions:

• Autophagy plays a protective role against methylglyoxal-induced apoptosis in kidney cells.
• AMPK signaling, rather than AKT/mTOR, mediates MGO-induced autophagy.
• Autophagy represents a potential therapeutic target for mitigating MGO-related kidney damage, including diabetic nephropathy.